⚠ For research purposes only — This certificate relates to the referenced lot only and is not an approval for human or veterinary use.
← Back to MOTS-C
Lab certificate (PDF)
Atlas RNDQuality Control · Released Records

Certificate of Analysis

DOC QC-COA-0108-MOTS-C-10-182-26 · REV 1
ProductMOTS-C
SKUATL-0108-10
LotMOTS-C-10-182-26
FormatLyophilized · 10 mg
ReportedJul 27, 2026
LaboratoryAxisPharm
CAS1627580-64-6
Best before07/2028
DispositionRELEASED

Triple-tested · Raw material is tested before vialing, the finished vial is tested for sterility, and every lot is released on an independent laboratory certificate.

Test results

Release test results for MOTS-C lot MOTS-C-10-182-26
TestMethodSpecificationResultVerdict
IdentityLC-MS Observed mass conforms to theoreticalConforms · LC-MS 2175.0[M+H] PASS
PurityHPLC-UV ≥ 95%99.00% PASS
Net contentLC-MS · gravimetric Report9.4 mg PASS

Source document

AxisPharm, LLC · Independent analytical laboratory. Reference 03Aug2026-06 · sample received Jul 27, 2026 · reported Jul 27, 2026.

The results above are transcribed from the laboratory's certificate for this lot. Atlas RND hosts a copy of that document; the original is the authority, so open it to confirm every figure.

Laboratory certificate (PDF)

NOT PART OF THIS LABORATORY'S PANEL FOR THIS LOT: APPEARANCE, ENDOTOXIN, MICROBIAL, ELEMENTAL IMPURITIES, FENTANYL SCREEN. ONLY TESTS THE LABORATORY RAN ARE LISTED.

Conclusion. Lot MOTS-C-10-182-26 of MOTS-C 10 mg meets the release specification for every test listed above and is approved for distribution for laboratory research use only. Testing performed by AxisPharm, LLC, an independent analytical laboratory, independent of Atlas RND.

Issued by the laboratoryAxisPharm, LLC · Jul 27, 2026
Reviewed for releaseAtlas RND quality control
VERIFY THIS DOCUMENT
www.atlasrnd.co/coa/mots-c-10-182-26
LAB REFERENCE 03Aug2026-06